Insys Therapeutics (INSY) – Analyst Ratings
-
Janney Downgrades INSYS Therapeutics (INSY) to Neutral
-
Cantor Fitzgerald Starts INSYS Therapeutics (INSY) at Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to INSY Stock Lookup